+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
ID07552922

Understanding Mens Preferences to Avoid Gynecomastia in High-Risk Biochemical Recurrence Prostate Cancer Treatment

Led by St Vincent's Hospital, Sydney · Updated on 2026-04-27

24

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to understand how men with prostate cancer PCa and high-risk biochemical recurrence BCR perceive the risk of breast-related side effects, such as gynaecomastia, that may result from their treatment. The study focuses on gathering views to help develop a future experiment that will evaluate patient preferences regarding these side effects in relation to quality of life and cancer control. This qualitative stage serves as a foundation for later research and is sponsored by St Vincents Hospital, Sydney. Men participating in the study will take part in semi-structured interviews. These interviews involve two groups men with high-risk BCR PCa who have not received androgen deprivation therapy ADT or androgen receptor pathway inhibitors ARPI, and men who have undergone ADT andor ARPI and experienced breast-related side effects. The collected insights will be used to identify key themes to design a discrete choice experiment DCE assessing trade-offs patients are willing to make between side effects and treatment benefits. Participants will share their personal experiences and perceptions during interviews, which will be analyzed over 12 months to identify themes and develop DCE attributes. Researchers will carefully explore how men weigh breast-related symptoms against other quality of life impacts and cancer control. This study does not involve treatment but focuses on gathering patient perspectives to inform future research design.

CONDITIONS

Brief Title

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here